These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32949963)

  • 41. Dual targeting of adenosine A(2A) receptors and monoamine oxidase B by 4H-3,1-benzothiazin-4-ones.
    Stössel A; Schlenk M; Hinz S; Küppers P; Heer J; Gütschow M; Müller CE
    J Med Chem; 2013 Jun; 56(11):4580-96. PubMed ID: 23631427
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel difluoromethyl-containing 1-((4-methoxy-3-(piperazin-1-yl)phenyl)sulfonyl)-1H-indole scaffold as potent 5-HT
    Yi C; Xue Y; Chen K; Wang T; Yu J; Wang Z; Jin C
    Bioorg Med Chem; 2022 Sep; 70():116917. PubMed ID: 35839536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Design, synthesis and evaluation of chalcone Mannich base derivatives as multifunctional agents for the potential treatment of Alzheimer's disease.
    Zhang X; Song Q; Cao Z; Li Y; Tian C; Yang Z; Zhang H; Deng Y
    Bioorg Chem; 2019 Jun; 87():395-408. PubMed ID: 30921741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Exploring Basic Tail Modifications of Coumarin-Based Dual Acetylcholinesterase-Monoamine Oxidase B Inhibitors: Identification of Water-Soluble, Brain-Permeant Neuroprotective Multitarget Agents.
    Pisani L; Farina R; Catto M; Iacobazzi RM; Nicolotti O; Cellamare S; Mangiatordi GF; Denora N; Soto-Otero R; Siragusa L; Altomare CD; Carotti A
    J Med Chem; 2016 Jul; 59(14):6791-806. PubMed ID: 27347731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine (F2MPA): A potential cognitive enhancer with MAO inhibitor properties.
    Di Giovanni G; García I; Colangeli R; Pierucci M; Rivadulla ML; Soriano E; Chioua M; Della Corte L; Yáñez M; De Deurwaerdère P; Fall Y; Marco-Contelles J
    CNS Neurosci Ther; 2014 Jul; 20(7):633-40. PubMed ID: 24848125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Searching for Multi-Targeting Neurotherapeutics against Alzheimer's: Discovery of Potent AChE-MAO B Inhibitors through the Decoration of the 2H-Chromen-2-one Structural Motif.
    Pisani L; Farina R; Soto-Otero R; Denora N; Mangiatordi GF; Nicolotti O; Mendez-Alvarez E; Altomare CD; Catto M; Carotti A
    Molecules; 2016 Mar; 21(3):362. PubMed ID: 26999091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis, pharmacological study and docking calculations of new benzo[f]coumarin derivatives as dual inhibitors of enzymatic systems involved in neurodegenerative diseases.
    Matos MJ; Janeiro P; González Franco RM; Vilar S; Tatonetti NP; Santana L; Uriarte E; Borges F; Fontenla JA; Viña D
    Future Med Chem; 2014 Mar; 6(4):371-83. PubMed ID: 24635520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Sang Z; Wang K; Shi J; Liu W; Tan Z
    Eur J Med Chem; 2019 Sep; 178():726-739. PubMed ID: 31229875
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel bifunctional drugs targeting monoamine oxidase inhibition and iron chelation as an approach to neuroprotection in Parkinson's disease and other neurodegenerative diseases.
    Youdim MB; Fridkin M; Zheng H
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1455-71. PubMed ID: 15480846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular determinants of MAO selectivity in a series of indolylmethylamine derivatives: biological activities, 3D-QSAR/CoMFA analysis, and computational simulation of ligand recognition.
    Morón JA; Campillo M; Perez V; Unzeta M; Pardo L
    J Med Chem; 2000 May; 43(9):1684-91. PubMed ID: 10794685
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesion.
    Cutillas B; Ambrosio S; Unzeta M
    Neurosci Lett; 2002 Aug; 329(2):165-8. PubMed ID: 12165403
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New 1-arylindoles based serotonin 5-HT7 antagonists. Synthesis and binding evaluation studies.
    Sagnes C; Fournet G; Satala G; Bojarski AJ; Joseph B
    Eur J Med Chem; 2014 Mar; 75():159-68. PubMed ID: 24531229
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-Alzheimer's multitarget-directed ligands with serotonin 5-HT
    Marcinkowska M; Bucki A; Panek D; Siwek A; Fajkis N; Bednarski M; Zygmunt M; Godyń J; Del Rio Valdivieso A; Kotańska M; Kołaczkowski M; Więckowska A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900041. PubMed ID: 31162703
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on the pharmacology of selective inhibitors of MAO-A and MAO-B: focus on modulation of CNS monoamine neurotransmitter release.
    Finberg JP
    Pharmacol Ther; 2014 Aug; 143(2):133-52. PubMed ID: 24607445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dual Target Ligands with 4-
    Łażewska D; Olejarz-Maciej A; Reiner D; Kaleta M; Latacz G; Zygmunt M; Doroz-Płonka A; Karcz T; Frank A; Stark H; Kieć-Kononowicz K
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32408504
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The computer-aided discovery of novel family of the 5-HT
    Łażewska D; Kurczab R; Więcek M; Kamińska K; Satała G; Jastrzębska-Więsek M; Partyka A; Bojarski AJ; Wesołowska A; Kieć-Kononowicz K; Handzlik J
    Eur J Med Chem; 2017 Jul; 135():117-124. PubMed ID: 28441580
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 6-Sulfonylbenzothiazolones as potential scaffolds for the design of 5-HT6 ligands.
    Larchanche PE; Ultré V; Le Broc D; Ballandone C; Furman C; Dallemagne P; Melnyk P; Carato P
    Eur J Med Chem; 2015 Mar; 92():807-17. PubMed ID: 25637882
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease.
    Weinstock M; Bejar C; Wang RH; Poltyrev T; Gross A; Finberg JP; Youdim MB
    J Neural Transm Suppl; 2000; (60):157-69. PubMed ID: 11205137
    [TBL] [Abstract][Full Text] [Related]  

  • 59. AVN-492, A Novel Highly Selective 5-HT6R Antagonist: Preclinical Evaluation.
    Ivachtchenko AV; Okun I; Aladinskiy V; Ivanenkov Y; Koryakova A; Karapetyan R; Mitkin O; Salimov R; Ivashchenko A
    J Alzheimers Dis; 2017; 58(4):1043-1063. PubMed ID: 28550249
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: in vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition.
    Zheng H; Gal S; Weiner LM; Bar-Am O; Warshawsky A; Fridkin M; Youdim MB
    J Neurochem; 2005 Oct; 95(1):68-78. PubMed ID: 16181413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.